LFCR
Lifecore Biomedical, Inc.
Price Chart
Latest Quote
$5.58
-0.22 (-3.79%)
Current Price
| Previous Close | $5.80 |
| Open | $5.81 |
| Day High | $5.85 |
| Day Low | $5.51 |
| Volume | 466,150 |
Stock Information
| Shares Outstanding | 37.51M |
| Total Debt | $150.14M |
| Cash Equivalents | $20.80M |
| Revenue | $129.46M |
| Net Income | $-34.50M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $209.30M |
| EPS (TTM) | $-1.27 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $396.12M |
| Sales | $129.46M |
| Income | $-34.50M |
| Book/sh | $-0.38 |
| Cash/sh | $0.55 |
| Employees | 382 |
Financial Ratios
| Quick Ratio | 2.18 |
| Current Ratio | 3.49 |
| Debt/Eq | 722.60 |
Returns & Margins
| Gross Margin | 31.37% |
| Operating Margin | -13.25% |
| Profit Margin | -23.78% |
Ownership
| Insider Ownership | 2.83% |
| Institutional Ownership | 77.19% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.89 |
| PEG | 2.66 |
| P/S | 1.62 |
| P/B | -14.72 |
Analyst Data
| Recommendation | buy |
| Target Price | $6.83 |
Technical Indicators
| SMA20 | $5.50 |
| SMA50 | $5.15 |
| SMA200 | $6.56 |
| RSI | 42.34 |
| ATR | 0.2757 |
| Shares Float | 19.45M |
| Short Float | 7.72% |
| Short Ratio | 12.21 |
| Volatility | 1.07 |
| Rel Volume | 2.34 |
Performance History
| Week | +1.09% |
| Month | +16.25% |
| Quarter | +33.17% |
| 6 Months | -31.70% |
| YTD | -27.91% |
| Year | -32.61% |
| 3 Years | -31.95% |
| 5 Years | -51.60% |
| 10 Years | -45.77% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $5.58 | 466,150 |
| 2026-06-24 | $5.80 | 145,700 |
| 2026-06-23 | $5.66 | 104,400 |
| 2026-06-22 | $5.53 | 131,200 |
| 2026-06-18 | $5.54 | 229,700 |
| 2026-06-17 | $5.52 | 159,600 |
| 2026-06-16 | $5.35 | 155,400 |
| 2026-06-15 | $5.49 | 185,400 |
| 2026-06-12 | $5.64 | 123,800 |
| 2026-06-11 | $5.65 | 111,400 |
| 2026-06-10 | $5.69 | 151,000 |
| 2026-06-09 | $5.66 | 163,100 |
| 2026-06-08 | $5.57 | 152,900 |
| 2026-06-05 | $5.63 | 138,200 |
| 2026-06-04 | $5.79 | 201,500 |
| 2026-06-03 | $5.67 | 404,300 |
| 2026-06-02 | $5.45 | 353,800 |
| 2026-06-01 | $4.85 | 177,700 |
| 2026-05-29 | $5.02 | 149,900 |
| 2026-05-28 | $4.97 | 275,500 |
| 2026-05-27 | $4.82 | 138,000 |
| 2026-05-26 | $4.80 | 118,000 |
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
đ° Latest News
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
Simply Wall St. âĸ 2026-06-13T05:06:31Z
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
Simply Wall St. âĸ 2026-05-29T01:03:57Z
Lifecore Biomedical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T13:07:52Z
Laughing Water Capitalâs Insights on Lifecore Biomedical (LFCR)
Insider Monkey âĸ 2026-04-27T11:47:45Z
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)?
Simply Wall St. âĸ 2026-04-04T12:29:30Z
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029
MarketBeat âĸ 2026-03-20T21:06:25Z
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-03-16T19:01:05ZLifecore Biomedical Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-16T15:00:21Z
What Contributes to Lifecore Biomedicalâs (LFCR) Distinct Competitive Advantage?
Insider Monkey âĸ 2026-01-16T13:25:56Z
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year
Simply Wall St. âĸ 2025-12-20T12:04:06Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $88,569,000 | $86,411,000 | $75,284,000 | $72,204,000 |
| Cost Of Revenue | $88,569,000 | $86,411,000 | $75,284,000 | $72,204,000 |
| Total Revenue | $128,867,000 | $128,261,000 | $103,269,000 | $111,270,000 |
| Operating Revenue | $128,867,000 | $128,261,000 | $103,269,000 | $111,270,000 |
| Expenses | ||||
| Interest Expense | $22,168,000 | $18,148,000 | $17,581,000 | $15,470,000 |
| Total Expenses | $140,873,000 | $135,449,000 | $122,989,000 | $114,702,000 |
| Other Income Expense | $-4,833,000 | $34,792,000 | $-26,627,000 | $-1,785,000 |
| Other Non Operating Income Expenses | $-3,000 | $-3,052,000 | $-810,000 | $6,574,000 |
| Net Non Operating Interest Income Expense | $-21,835,000 | $-18,090,000 | $-17,581,000 | $-15,470,000 |
| Interest Expense Non Operating | $22,168,000 | $18,148,000 | $17,581,000 | $15,470,000 |
| Operating Expense | $52,304,000 | $49,038,000 | $47,705,000 | $42,498,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-38,717,000 | $9,331,000 | $-64,236,000 | $-15,476,000 |
| Net Interest Income | $-21,835,000 | $-18,090,000 | $-17,581,000 | $-15,470,000 |
| Interest Income | $333,000 | $58,000 | $68,000 | $81,000 |
| Normalized Income | $-34,901,300 | $-27,785,078 | $-43,840,570 | $-9,222,632 |
| Net Income From Continuing And Discontinued Operation | $-38,717,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Total Operating Income As Reported | $-17,245,000 | $-8,844,000 | $-21,796,000 | $-11,791,000 |
| Net Income Common Stockholders | $-44,359,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Net Income | $-38,717,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Net Income Including Noncontrolling Interests | $-38,717,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Net Income Discontinuous Operations | $0 | $2,682,000 | $-35,327,000 | $-101,239,000 |
| Net Income Continuous Operations | $-38,717,000 | $9,331,000 | $-64,236,000 | $-15,476,000 |
| Pretax Income | $-38,674,000 | $9,514,000 | $-63,928,000 | $-20,687,000 |
| Special Income Charges | $-5,239,000 | $-1,656,000 | $-25,817,000 | $-8,359,000 |
| Interest Income Non Operating | $333,000 | $58,000 | $68,000 | $81,000 |
| Operating Income | $-12,006,000 | $-7,188,000 | $-19,720,000 | $-3,432,000 |
| Gross Profit | $40,298,000 | $41,850,000 | $27,985,000 | $39,066,000 |
| Per Share | ||||
| Diluted EPS | $-1.27 | $0.32 | $-3.41 | $-3.30 |
| Basic EPS | $-1.27 | $0.40 | $-3.41 | $-3.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,014,300 | $727,922 | $-5,421,570 | $-2,105,632 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,649,000 | $-2,228,000 | $-7,353,000 | $21,203,000 |
| Total Unusual Items | $-4,830,000 | $37,844,000 | $-25,817,000 | $-8,359,000 |
| Total Unusual Items Excluding Goodwill | $-4,830,000 | $37,844,000 | $-25,817,000 | $-8,359,000 |
| Reconciled Depreciation | $8,027,000 | $7,954,000 | $13,177,000 | $18,061,000 |
| EBITDA (Bullshit earnings) | $-8,479,000 | $35,616,000 | $-33,170,000 | $12,844,000 |
| EBIT | $-16,506,000 | $27,662,000 | $-46,347,000 | $-5,217,000 |
| Diluted Average Shares | $34,818,906 | $36,658,000 | $29,967,742 | $29,513,000 |
| Basic Average Shares | $34,818,906 | $30,474,000 | $29,967,742 | $29,513,000 |
| Diluted NI Availto Com Stockholders | $-44,359,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Otherunder Preferred Stock Dividend | $2,324,000 | $0 | - | - |
| Preferred Stock Dividends | $3,318,000 | - | - | - |
| Tax Provision | $43,000 | $183,000 | $308,000 | $-5,211,000 |
| Gain On Sale Of Ppe | $-6,986,000 | $0 | - | - |
| Restructuring And Mergern Acquisition | $-1,747,000 | $1,656,000 | $4,184,000 | $8,359,000 |
| Gain On Sale Of Security | $409,000 | $39,500,000 | - | - |
| Research And Development | $8,258,000 | $8,575,000 | $8,736,000 | $7,839,000 |
| Selling General And Administration | $44,046,000 | $40,463,000 | $38,969,000 | $34,659,000 |
| Gain On Sale Of Business | - | $0 | $2,108,000 | $0 |
| Other Special Charges | - | - | $23,741,000 | - |
| Impairment Of Capital Assets | - | - | - | $28,735,000 |
Fetched: 2026-06-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-28,083,000 | $-12,545,000 | $-2,566,000 | $-22,311,000 |
| Total Assets | $232,177,000 | $239,342,000 | $253,960,000 | $253,545,000 |
| Total Non Current Assets | $149,885,000 | $153,665,000 | $172,927,000 | $159,670,000 |
| Other Non Current Assets | $8,700,000 | $10,778,000 | $9,881,000 | $2,917,000 |
| Goodwill And Other Intangible Assets | $13,881,000 | $13,881,000 | $13,881,000 | $18,081,000 |
| Current Assets | $82,292,000 | $85,677,000 | $81,033,000 | $93,875,000 |
| Other Current Assets | $1,921,000 | $1,454,000 | $1,439,000 | $4,919,000 |
| Inventory | $29,085,000 | $32,291,000 | $39,979,000 | $40,841,000 |
| Receivables | $33,817,000 | $43,667,000 | $31,153,000 | $29,024,000 |
| Other Receivables | $7,655,000 | $6,979,000 | $4,069,000 | - |
| Notes Receivable | $0 | $8,000,000 | $0 | - |
| Accounts Receivable | $26,162,000 | $28,688,000 | $27,084,000 | $29,024,000 |
| Allowance For Doubtful Accounts Receivable | $-1,044,000 | $-1,351,000 | $-711,000 | $-485,000 |
| Gross Accounts Receivable | $27,206,000 | $30,039,000 | $27,795,000 | $29,509,000 |
| Cash Cash Equivalents And Short Term Investments | $17,469,000 | $8,265,000 | $8,462,000 | $19,091,000 |
| Cash And Cash Equivalents | $17,469,000 | $8,265,000 | $8,462,000 | $19,091,000 |
| Other Intangible Assets | - | $4,200,000 | $4,200,000 | $4,200,000 |
| Assets Held For Sale Current | - | - | - | $0 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $118,892,000 | $122,171,000 | $116,206,000 | $82,554,000 |
| Total Debt | $142,608,000 | $130,823,000 | $128,631,000 | $112,624,000 |
| Long Term Debt And Capital Lease Obligation | $141,282,000 | $126,999,000 | $123,725,000 | $110,774,000 |
| Long Term Debt | $135,588,000 | $126,999,000 | $123,725,000 | $101,065,000 |
| Current Debt And Capital Lease Obligation | $1,326,000 | $3,824,000 | $4,906,000 | $1,850,000 |
| Current Debt | $773,000 | $3,437,000 | $943,000 | $580,000 |
| Other Current Borrowings | $773,000 | $3,437,000 | $943,000 | $580,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $246,379,000 | $238,006,000 | $242,645,000 | $257,775,000 |
| Total Non Current Liabilities Net Minority Interest | $222,806,000 | $207,828,000 | $203,773,000 | $218,486,000 |
| Other Non Current Liabilities | $6,698,000 | $9,741,000 | $12,061,000 | $174,000 |
| Derivative Product Liabilities | $26,564,000 | $24,991,000 | $25,400,000 | $64,900,000 |
| Current Liabilities | $23,573,000 | $30,178,000 | $38,872,000 | $39,289,000 |
| Other Current Liabilities | $1,498,000 | $1,844,000 | $1,552,000 | - |
| Current Deferred Liabilities | $8,660,000 | $3,415,000 | $2,113,000 | $4,055,000 |
| Payables And Accrued Expenses | $7,541,000 | $14,951,000 | $24,136,000 | $29,239,000 |
| Payables | $5,839,000 | $12,719,000 | $19,805,000 | $22,097,000 |
| Accounts Payable | $5,839,000 | $8,220,000 | $16,334,000 | $22,097,000 |
| Other Payable | - | $4,499,000 | $3,471,000 | - |
| Non Current Deferred Liabilities | - | - | $5,246,000 | $3,320,000 |
| Non Current Deferred Taxes Liabilities | - | - | $543,000 | $380,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $-14,202,000 | $1,336,000 | $11,315,000 | $-4,230,000 |
| Total Equity Gross Minority Interest | $-14,202,000 | $1,336,000 | $11,315,000 | $-4,230,000 |
| Stockholders Equity | $-14,202,000 | $1,336,000 | $11,315,000 | $-4,230,000 |
| Retained Earnings | $-223,201,000 | $-205,240,000 | $-166,523,000 | $-178,536,000 |
| Preferred Securities Outside Stock Equity | $48,262,000 | $46,097,000 | $42,587,000 | $39,318,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $0 |
| Other Equity Adjustments | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $37,477,386 | $37,026,234 | $30,563,000 | $29,513,000 |
| Share Issued | $37,477,386 | $37,026,234 | $30,563,000 | $29,513,000 |
| Tangible Book Value | $-28,083,000 | $-12,545,000 | $-2,566,000 | $-22,311,000 |
| Invested Capital | $122,159,000 | $131,772,000 | $135,983,000 | $97,415,000 |
| Working Capital | $58,719,000 | $55,499,000 | $42,161,000 | $54,586,000 |
| Capital Lease Obligations | $6,247,000 | $387,000 | $3,963,000 | $10,979,000 |
| Total Capitalization | $121,386,000 | $128,335,000 | $135,040,000 | $96,835,000 |
| Additional Paid In Capital | $208,962,000 | $206,539,000 | $177,807,000 | $174,276,000 |
| Capital Stock | $37,000 | $37,000 | $31,000 | $30,000 |
| Common Stock | $37,000 | $37,000 | $31,000 | $30,000 |
| Long Term Capital Lease Obligation | $5,694,000 | - | $4,944,000 | $9,709,000 |
| Current Deferred Revenue | $8,660,000 | $3,415,000 | $2,113,000 | $4,055,000 |
| Current Capital Lease Obligation | $553,000 | $387,000 | $3,963,000 | $1,270,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,548,000 | $6,144,000 | $6,165,000 | $4,145,000 |
| Current Accrued Expenses | $1,702,000 | $2,232,000 | $4,331,000 | $7,142,000 |
| Goodwill | $13,881,000 | $13,881,000 | $13,881,000 | $13,881,000 |
| Net PPE | $127,304,000 | $129,006,000 | $149,165,000 | $138,672,000 |
| Accumulated Depreciation | $-59,160,000 | $-57,412,000 | $-50,334,000 | $-57,006,000 |
| Gross PPE | $186,464,000 | $186,418,000 | $199,499,000 | $195,678,000 |
| Construction In Progress | $9,539,000 | $47,756,000 | $61,952,000 | $45,587,000 |
| Machinery Furniture Equipment | $91,413,000 | $71,191,000 | $70,934,000 | $77,363,000 |
| Buildings And Improvements | $82,021,000 | $63,732,000 | $62,874,000 | $60,688,000 |
| Land And Improvements | $3,491,000 | $3,739,000 | $3,739,000 | $3,739,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $11,845,000 | $13,379,000 | $14,924,000 | $13,141,000 |
| Work In Process | $7,148,000 | $8,743,000 | $11,915,000 | $10,349,000 |
| Raw Materials | $10,092,000 | $10,169,000 | $13,140,000 | $17,735,000 |
| Non Current Deferred Revenue | - | - | $4,703,000 | $2,940,000 |
| Leases | - | - | $0 | $4,019,000 |
| Other Properties | - | - | $2,442,000 | $4,282,000 |
| Inventories Adjustments Allowances | - | - | $-1,415,000 | $-384,000 |
| Line Of Credit | - | - | - | $0 |
| Investments And Advances | - | - | - | - |
| Other Investments | - | - | - | - |
Fetched: 2026-06-25
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,621,000 | $-18,138,000 | $-38,923,000 | $-52,533,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-206,000 | $257,000 | $-17,441,000 | $-22,593,000 |
| Cash Flow From Continuing Operating Activities | $-206,000 | $257,000 | $-17,441,000 | $-22,593,000 |
| Operating Gains Losses | $7,367,000 | $-39,482,000 | $42,653,000 | $5,673,000 |
| Investing Activities | ||||
| Capital Expenditure | $-13,415,000 | $-18,395,000 | $-21,482,000 | $-29,940,000 |
| Investing Cash Flow | $-6,415,000 | $-18,395,000 | $-4,811,000 | $79,962,000 |
| Cash Flow From Continuing Investing Activities | $-6,415,000 | $-18,395,000 | $-4,811,000 | $79,962,000 |
| Net Other Investing Changes | - | - | - | $-9,839,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $23,850,000 | $0 | $42,904,000 | $0 |
| Financing Cash Flow | $6,424,000 | $7,509,000 | $39,700,000 | $-57,021,000 |
| Cash Flow From Continuing Financing Activities | $6,424,000 | $7,509,000 | $39,700,000 | $-57,021,000 |
| Net Other Financing Charges | $-1,365,000 | $4,779,000 | $-6,324,000 | $-1,610,000 |
| Net Common Stock Issuance | $23,850,000 | $0 | $4,822,000 | $0 |
| Common Stock Issuance | $23,850,000 | $0 | $4,822,000 | $0 |
| Net Preferred Stock Issuance | - | $0 | $38,082,000 | $0 |
| Preferred Stock Issuance | - | $0 | $38,082,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-145,758,000 | $-146,704,000 | $-178,330,000 | $-130,522,000 |
| Issuance Of Debt | $130,967,000 | $149,586,000 | $181,450,000 | $75,111,000 |
| Interest Paid Supplemental Data | $1,907,000 | $2,730,000 | $31,024,000 | $16,888,000 |
| Income Tax Paid Supplemental Data | $46,000 | $72,000 | $23,000 | $441,000 |
| End Cash Position | $8,265,000 | $8,462,000 | $19,091,000 | $1,643,000 |
| Beginning Cash Position | $8,462,000 | $19,091,000 | $1,643,000 | $1,295,000 |
| Changes In Cash | $-197,000 | $-10,629,000 | $17,448,000 | $348,000 |
| Proceeds From Stock Option Exercised | $-1,270,000 | $-152,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $-14,791,000 | $2,882,000 | $3,120,000 | $-55,411,000 |
| Net Long Term Debt Issuance | $-14,791,000 | $2,882,000 | $3,120,000 | $-55,411,000 |
| Long Term Debt Payments | $-145,758,000 | $-146,704,000 | $-178,330,000 | $-130,522,000 |
| Long Term Debt Issuance | $130,967,000 | $149,586,000 | $181,450,000 | $75,111,000 |
| Net PPE Purchase And Sale | $-6,415,000 | $-18,395,000 | $-21,482,000 | $-28,799,000 |
| Sale Of PPE | $7,000,000 | $0 | $0 | $1,141,000 |
| Purchase Of PPE | $-13,415,000 | $-18,395,000 | $-21,482,000 | $-29,940,000 |
| Change In Working Capital | $-4,695,000 | $-3,699,000 | $19,791,000 | $-3,101,000 |
| Change In Other Current Assets | $378,000 | $2,854,000 | $2,156,000 | $-689,000 |
| Change In Payables And Accrued Expense | $-7,589,000 | $-5,023,000 | $15,546,000 | $5,924,000 |
| Change In Accrued Expense | $-5,919,000 | $1,653,000 | $-492,000 | $-3,419,000 |
| Change In Payable | $-1,670,000 | $-6,676,000 | $16,038,000 | $9,343,000 |
| Change In Account Payable | $-1,670,000 | $-6,676,000 | $16,038,000 | $9,343,000 |
| Change In Inventory | $7,688,000 | $862,000 | $-14,811,000 | $-2,180,000 |
| Change In Receivables | $-5,172,000 | $-2,392,000 | $10,824,000 | $-6,138,000 |
| Changes In Account Receivables | $-2,262,000 | $-3,263,000 | $10,824,000 | $-6,138,000 |
| Other Non Cash Items | $17,654,000 | $17,270,000 | $1,069,000 | $-426,000 |
| Stock Based Compensation | $10,158,000 | $6,201,000 | $3,612,000 | $2,608,000 |
| Depreciation Amortization Depletion | $8,027,000 | $7,954,000 | $13,177,000 | $18,061,000 |
| Depreciation And Amortization | $8,027,000 | $7,954,000 | $13,177,000 | $18,061,000 |
| Depreciation | $8,027,000 | $7,954,000 | $13,285,000 | $17,884,000 |
| Gain Loss On Investment Securities | $-409,000 | $-39,500,000 | - | - |
| Gain Loss On Sale Of PPE | $7,776,000 | $18,000 | $38,000 | $5,337,000 |
| Net Income From Continuing Operations | $-38,717,000 | $12,013,000 | $-99,563,000 | $-116,715,000 |
| Net Investment Purchase And Sale | - | $0 | $0 | $45,100,000 |
| Sale Of Investment | - | $0 | $0 | $45,100,000 |
| Net Business Purchase And Sale | - | $0 | $16,671,000 | $73,500,000 |
| Sale Of Business | - | $0 | $16,671,000 | $73,500,000 |
| Change In Other Working Capital | - | $-179,000 | $6,076,000 | $-18,000 |
| Provisionand Write Offof Assets | - | $263,000 | $163,000 | $-14,000 |
| Asset Impairment Charge | - | $0 | $1,300,000 | $78,146,000 |
| Deferred Tax | - | $163,000 | $357,000 | $-6,825,000 |
| Deferred Income Tax | - | $163,000 | $357,000 | $-6,825,000 |
| Gain Loss On Sale Of Business | - | $0 | $18,874,000 | $336,000 |
| Net Short Term Debt Issuance | - | - | $-54,640,000 | $-44,111,000 |
| Short Term Debt Payments | - | - | $-54,640,000 | $-44,111,000 |
| Short Term Debt Issuance | - | - | $31,450,000 | $55,111,000 |
| Purchase Of Business | - | - | $0 | $-9,839,000 |
| Change In Prepaid Assets | - | - | $2,156,000 | $-602,000 |
Fetched: 2026-06-25